Refer to Attachment 7 Reconciliation of Non-GAAP Financial Measures for details regarding adjustments to previously reported results to arrive to the pro forma financial metrics. 2 Webcast Details The company will host a webcast at 9:00 a.m. See Attachment 3 for a definition and summary of special items and Attachment 7 for a summary of pro forma adjustments associated with the Clariant MB Acquisition necessary to reflect Clariant MB adjusted results in all periods presented. Three Months Ended Year Ended Sales: Color, Additives and Inks $ 525.8 $ 226.7 $ 1,502.9 $ 1,003.8 Specialty Engineered Materials 190.6 177.5 708.8 745.7 Distribution 305.1 272.4 1,110.3 1,192.2 Corporate and eliminations (24.5) (18.0) (79.9) (79.0) Sales $ 997.0 $ 658.6 $ 3,242.1 $ 2,862.7 Gross margin: Color, Additives and Inks $ 164.3 $ 73.9 $ 484.4 $ 338.4 Specialty Engineered Materials 59.1 47.7 207.6 200.2 Distribution 32.4 31.0 124.0 132.1 Corporate and eliminations (2.9) 0.7 (31.7) (13.5) Gross margin $ 252.9 $ 153.3 $ 784.3 $ 657.2 Selling and administrative expense: Color, Additives and Inks $ 106.8 $ 46.7 $ 303.6 $ 191.0 Specialty Engineered Materials 28.7 28.9 113.2 116.5 Distribution 14.4 14.0 54.5 56.7 Corporate and eliminations 38.0 43.2 123.7 136.2 Selling and administrative expense $ 187.9 $ 132.8 $ 595.0 $ 500.4 Operating income: Color, Additives and Inks $ 57.5 $ 27.2 $ 180.8 $ 147.4 Specialty Engineered Materials 30.4 18.8 94.4 83.7 Distribution 18.0 17.0 69.5 75.4 Corporate and eliminations (40.9) (42.5) (155.4) (149.7) Operating income $ 65.0 $ 20.5 $ 189.3 $ 156.8 11 Attachment 7 Reconciliation of Non-GAAP Financial Measures (Unaudited) Senior management uses gross margin before special items and operating income before special items to assess performance and allocate resources because senior management believes that these measures are useful in understanding current profitability levels and how it may serve as a basis for future performance.

Refer to Attachment 7 Reconciliation of Non-GAAP Financial Measures for details regarding adjustments to previously reported results to arrive to the pro forma financial metrics. Rose Vice President, Corporate Communications Avient Corporation +1 440-930-3162 kyle.rose@avient.com mailto:giuseppe.disalvo@avient.com mailto:kyle.rose@avient.com 7 Attachment 1 Avient Corporation Summary of Condensed Consolidated Statements of Income (Unaudited) (In millions, except per share data) Three Months Ended December 31, Year Ended December 31, 2021 2020 2021 2020 Sales $ 1,201.5 $ 997.0 $ 4,818.8 $ 3,242.1 Operating Income 74.0 65.0 381.2 189.3 Net income from continuing operations attributable to Avient shareholders 29.8 74.2 230.8 132.0 Basic earnings per share from continuing operations attributable to Avient shareholders $ 0.33 $ 0.81 $ 2.53 $ 1.47 Diluted earnings per share from continuing operations attributable to Avient shareholders $ 0.32 $ 0.81 $ 2.51 $ 1.46 Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results. See Attachment 3 for a definition and summary of special items and Attachment 7 for a summary of pro forma adjustments associated with the Clariant Color Acquisition necessary to reflect Clariant Color adjusted results in all periods presented.

Antitrust Laws 2 Antitrust Law Violations 3 Antitrust Potential Areas of Concern 3 Conclusion 5 Reporting Possible Violations 6 Avient Ethics Hotline 6 Protection from Retaliation 6 Antitrust Checklist 7 Quick Reference: Antitrust DO’s and DON’Ts 9 Guide For Compliance Avient is committed to promoting fair competition and free enterprise in the marketplace. Do not attend meetings with competitors (including trade association gatherings) at which prices or any of the foregoing subjects are discussed. 7. Even in the Antitrust Checklist 7 first instance, make every effort to verify and document the competing price prior to offering a distributor a lower price intended to meet that competitive price; do not, however, attempt to verify the competing price by contacting the competitor directly.

Most temporary antistatic additives require time to reach maximum effectiveness, typically 2 to 7 days.

Глобальная антимонопольная политика компании Avient Содержание Общие сведения о политике 1 Общий обзор Антимонопольного законодательства США 2 Нарушения антимонопольного законодательства 3 Потенциальные проблемные области в сфере антимонопольного законодательства 3 Заключение 6 Фиксация возможных нарушений 7 Горячая линия по вопросам этики компании Avient 7 Защита от преследований 7 Контрольный список по соблюдению требований антимонопольного законодательства 8 Краткий справочник: Что следует и не следует делать в рамках антимонопольной политики 10 Руководство по нормативно- правовому соответствию Компания Avient привержена созданию справедливой конкуренции и свободного предпринимательства на рынке. Горячая линия по вопросам этики компании https://www.Avient.com/company/policies-and- governance/ethics-hotline телефону 1-877-228-5410 7 mailto:ethics.officer%40avient.com%20%20? Не присутствуйте на встречах с конкурентами (включая собрания торговых ассоциаций), где обсуждаются цены или любые упомянутые выше темы. 7.

MEDICAL EQUIPMENT MANUFACTURER S U R G I C A L X - R A Y G L A S S E S • Replace lead while providing uniform shielding performance • Radiation shielding up to 140KeV • Improve glasses design • Compliance with Radiation Protection Regulation: Adult eye exposure must be below 20 mSv per calendar year • Conducted extensive testing to ensure comparable and uniform shielding performance • Improved geometric flexibility • Lowered shielding component costs 30-50% by eliminating machining and assembly steps (associated with lead) • Reduced weight of the glasses and enabled a more ergonomic design • Eliminated disposal concerns associated with lead Trilliant™ XR Lead Replacement Thermoplastics KEY REQUIREMENTS WHY AVIENT?

ELECTRICAL PARTS MANUFACTURER H E A V Y D U T Y C O N N E C T O R S A N D A C C E S S O R I E S • Reduce material rematching and rejection through more efficient pre-testing • Improve processing efficiencies and color consistency in highly FR-filled and high-temperature resins • Achieve regulatory compliance across multiple resin families • Gain better supply chain control to manage scarcity of key engineering resins and changing resin producers • Offered eight UL 94-recognized sites in U.S. and Canada that perform comprehensive analytical, physical and mechanical testing • Provided increased speed to market and expedited design timelines for new products using existing standardized and pre- approved color palettes • Ensured regulatory compliance and security of supply OnColor™ UL 94 Colorants KEY REQUIREMENTS WHY AVIENT AVIENT SOLUTION QUALITY + SPEED TO MARKET LEARN MORE © 2023, Avient Corporation, All Rights Reserved https://www.avient.com/products/polymer-colorants/solid-color-masterbatches/oncolor-ul94-colorants

Glucose Monitoring App Snapshot draft MEDICAL DEVICE OEM C O N T I N U O U S G L U C O S E M O N I T O R I N G S Y S T E M • Adapt to strict processing requirements of a secondary operation put in place to manufacture a new device model • Meet material size and thickness requirements while achieving desired color target • Overcome material unpredictability and sensitivity to heat, light and moisture • Minimize impact of supply chain instability and changes • Offered support for processing under low pressure conditions and at every stage of manufacturing • Performed extensive R&D work to consistently deliver the customer’s color target of a hard-to-achieve light gray • Effectively addressed all material challenges and sensitivities • Provided regular ‘summaries of understanding’ to keep up with changing forecasts and ordering patterns Mevopur™ Pre-color Formulation KEY REQUIREMENTS WHY AVIENT?

Wire & cable manufacturer WIRE & CABLE MANUFACTURER A E R O N A U T I C D A T A T R A N S M I S S I O N C A B L E S • Permanent contrast marking meeting aerospace industry standards SAE AS4373F and EN-3475-706 • Benign marking that, compared to infrared (IR) laser marking, will not damage the jacket surface • Elevated temperature performance in corrosive environments, maintaining dielectric properties under continuous service • No vital optical fiber or data transmission cable interference • Demonstrated fluorinated ethylene propylene (FEP) application expertise incorporating laser marks • Provided formulation expertise in PTFE alternatives • Delivered a high-quality product with no clumping during the extrusion process • Offered a proven array of specific aeronautic colors • Provided commercial, technical, and operational support KEY REQUIREMENTS APPEARANCE + PERFORMANCE WHY AVIENT?

MEDICAL EQUIPMENT MANUFACTURER C L O S E D S Y S T E M D R U G T R A N S F E R D E V I C E • A new material for a seal inside the next generation of closed system drug transfer device • Compliance with stringent regulatory standards: • Biocompatibility to ISO10993 • USP VI compliance • Provided regulatory support services and expertise throughout extensive medical approval process • Provided a custom formulation compliant with the highest healthcare regulatory standards • Enabled material to be manufactured and shipped globally Custom Versalloy™ HC 9220-90 Formulation KEY REQUIREMENTS WHY AVIENT?